Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia

The prion protein (PrP) is central to the prion diseases, although a role in other neurodegenerative diseases has been postulated. A common polymorphism (Met or Val) at codon 129 of the PrP gene (PRNP) features prominently in the risk and phenotype, of prion disease, and an abnormality in its distribution frequency may signal a role for PrP in other diseases. We conducted a case–control study to compare the PRNP codon 129 genotype distribution in Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and primary progressive aphasia (PPA), including 281 AD, 256 ALS, 39 PPA, and 415 healthy control subjects. Statistical analysis was applied to determine the presence or absence of disease‐specific genotype associations. The distribution of codon 129 genotypes was similar among healthy control, AD, and ALS subjects, although the heterozygous state was significantly overrepresented (age‐adjusted odds ratio, 8.47) in PPA, a rare condition of unknown cause. Although these findings do not entirely exclude a role for PrP in AD or ALS, they do not support the codon 129 genotype as a risk factor for either disease. However, the strong association between heterozygosity and PPA raises new questions about its cause and the role of PrP in other neurodegenerative diseases. Ann Neurol 2005;58:858–864

[1]  J. Warter,et al.  Basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease , 1999, Neurology.

[2]  C. Duyckaerts,et al.  [Neuropsychological and scintigraphic aspects of frontotemporal dementia preceding amyotrophic lateral sclerosis]. , 2003, Revue neurologique.

[3]  A. Hofman,et al.  Early cognitive decline is associated with prion protein codon 129 polymorphism , 2003, Annals of neurology.

[4]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[5]  C. Henry,et al.  Clinical features of variant Creutzfeldt‐Jakob disease , 2002, Reviews in medical virology.

[6]  A. LeBlanc,et al.  Prion Protein Protects Human Neurons against Bax-mediated Apoptosis* , 2001, The Journal of Biological Chemistry.

[7]  C. Lomen‐Hoerth,et al.  Characterization of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia , 2004, Dementia and Geriatric Cognitive Disorders.

[8]  M. Franceschi,et al.  Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline? , 2001, Journal of neurology, neurosurgery, and psychiatry.

[9]  J. Hauw,et al.  Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing , 2003, Acta Neuropathologica.

[10]  P. Amouyel,et al.  Polymorphism of the prion protein is associated with cognitive impairment in the elderly , 1998, Neurology.

[11]  D. Dickson,et al.  Familial Primary Progressive Aphasia , 2003, Alzheimer disease and associated disorders.

[12]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[13]  T. Asada,et al.  Absence of association between codon 129/219 polymorphisms of the prion protein gene and Alzheimer's disease in Japan , 2003, Annals of neurology.

[14]  S H Ferris,et al.  Neuropsychological Prediction of Decline to Dementia in Nondemented Elderly , 1999, Journal of geriatric psychiatry and neurology.

[15]  M. Mesulam,et al.  Primary progressive aphasia--a language-based dementia. , 2003, The New England journal of medicine.

[16]  J. Laplanche,et al.  Signal transduction through prion protein. , 2000, Science.

[17]  A. Aguzzi,et al.  Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. , 2004, Brain : a journal of neurology.

[18]  John Collinge,et al.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease , 1991, Nature.

[19]  J Q Trojanowski,et al.  Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.

[20]  D. Dickson,et al.  Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS , 2003, Neuropathology and applied neurobiology.

[21]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[22]  R. Petersen,et al.  Fatal Familial Insomnia and Familial Creutzfeldt‐Jakob Disease: Clinical, Pathological and Molecular Features , 1995, Brain pathology.

[23]  Y. Agid,et al.  Incubation period of Creutzfeldt–Jakob disease in human growth hormone recipients in France , 1999, Neurology.

[24]  D. Gajdusek,et al.  Genetic studies in relation to kuru: an overview. , 2004, Current molecular medicine.

[25]  W. Snow,et al.  The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimerʼs disease: a clinicopathologic study of 57 cases , 1988 .

[26]  J. Kimura,et al.  A case of primary progressive aphasia with abnormally ubiquitinated neurites in the cerebral cortex , 1996, Acta Neuropathologica.

[27]  Raymond Scott Turner,et al.  Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia , 1996, Annals of neurology.

[28]  D. Neary,et al.  Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) , 2000, Journal of the Neurological Sciences.

[29]  D. Dormont,et al.  Genotype at codon 129 and susceptibility to Creutzfeldt-Jakob disease , 1998, The Lancet.

[30]  Andrew Kertesz,et al.  Primary progressive aphasia and Pick complex , 2003, Journal of the Neurological Sciences.

[31]  O. Combarros,et al.  Polymorphism at codon 129 of the prion protein gene is not associated with sporadic AD , 2000, Neurology.

[32]  R. Will,et al.  Clinical features of variant Creutzfeldt-Jakob disease. , 2004, Current topics in microbiology and immunology.

[33]  S. Haswell,et al.  Normal prion protein has an activity like that of superoxide dismutase. , 1999, The Biochemical journal.

[34]  D. Westaway,et al.  The cellular prion protein binds copper in vivo , 1997, Nature.

[35]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[36]  M. Mesulam,et al.  Apolipoprotein E genotypes in primary progressive aphasia , 1997, Neurology.

[37]  S. Prusiner,et al.  Inherited prion disease caused by the V210I mutation , 2001, Neurology.

[38]  H. Budka,et al.  Mutations of the prion protein gene phenotypic spectrum. , 2002, Journal of neurology.

[39]  J. Metso,et al.  Apolipoprotein A-IV polymorphism in the Finnish population: gene frequencies and description of a rare allele. , 1988, Human heredity.

[40]  D. Geschwind,et al.  Possible association of the tau H1/H1 genotype with primary progressive aphasia , 2003, Neurology.

[41]  T. Crow,et al.  Codon 129 changes in the prion protein gene in Caucasians. , 1990, American journal of human genetics.

[42]  C. Sigurdson,et al.  [Prion diseases?]. , 1985, Deutsche medizinische Wochenschrift.

[43]  A. Hofman,et al.  PRNP Val129 homozygosity increases risk for early‐onset Alzheimer's disease , 2003, Annals of neurology.